abnormal pancreatic islet morphology, abnormal sleep pattern, abnormal spleen B cell follicle morphology, abnormal spleen marginal zone morphology, abnormal spleen periarteriolar lymphoid sheath morphology, abnormal spleen white pulp morphology, abnormal thymus epithelium morphology, abnormal thymus medulla morphology, absent Peyer's patches, absent axillary lymph nodes, absent brachial lymph nodes, absent cervical lymph nodes, absent inguinal lymph nodes, absent lymph nodes, absent marginal zone B cells, absent mesenteric lymph nodes, absent peripheral lymph nodes, absent popliteal lymph nodes, absent spleen germinal center, absent spleen marginal zone, decreased IgG1 level, decreased IgG2a level, decreased IgG3 level, decreased circulating interferon-gamma level, decreased interferon-gamma secretion, decreased sensitivity to induced morbidity/mortality, decreased spleen white pulp amount, decreased susceptibility to endotoxin shock, decreased susceptibility to experimental autoimmune encephalomyelitis, decreased susceptibility to induced arthritis, decreased susceptibility to parasitic infection, decreased transitional stage B cell number, decreased tumor necrosis factor secretion, impaired macrophage phagocytosis, increased B-1b cell number, increased body length, increased body mass index, increased bronchoconstrictive response, increased circulating alkaline phosphatase level, increased heart weight, increased liver weight, increased neutrophil cell number, increased pulmonary ventilation, increased sensitivity to induced morbidity/mortality, increased spleen weight, increased susceptibility to Poxviridae infection, increased susceptibility to Riboviria infection, increased susceptibility to bacterial infection induced morbidity/mortality, increased susceptibility to diet-induced obesity, increased susceptibility to injury, increased susceptibility to parasitic infection, insulitis, liver/biliary system phenotype, periinsulitis, small thymus medulla